Marguerite Monogue

8PUBLICATIONS
15CO-AUTHORS
PharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyEnvironmental epidemiologyMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 20, 2026
Antimicrobial Pharmacokinetic and Pharmacodynamic Considerations in Special Populations: A Call to Action.

Marguerite L Monogue, James M Sanders, Nicholas J Mercuro

|Jun 27, 2025
Clinical validation of antimicrobial dosing regimens for continuous renal replacement therapy based on an ex vivo dosing algorithm.

Christina Koenig, Cole P McGrath, Hanna F Roenfanz

|Jun 05, 2025
Vancomycin Monitoring for Treatment of Acute Pulmonary Exacerbations of Adult Cystic Fibrosis Patients.

Darrell Smith, James Sanders, Marguerite Monogue

|Dec 10, 2024
Cefiderocol pharmacokinetics during acute pulmonary exacerbations in hospitalized adult persons with cystic fibrosis.

Christina Koenig, Marguerite L Monogue, Ryan K Shields

|Nov 20, 2023
In vitro activity of cefiderocol against Pseudomonas aeruginosa isolated from cystic fibrosis patients.

Marguerite L Monogue, Dhara Desai, Christine A Pybus

|Jul 13, 2023
Ceftolozane/tazobactam heteroresistance in cystic fibrosis-related Pseudomonas aeruginosa infections.

Marguerite L Monogue, James M Sanders, Christine A Pybus

Pageof 2